SCHEMBL7680685

SCHEMBL7680685

COc1ccc(N(C)c2nc(C)cc(C)n2)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 3/20 0.52
EGFR P00533 1/20 0.51
PDGFRB P09619 1/20 0.51
PDGFRA P16234 1/20 0.51
KDR P35968 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
LMNA P02545 2/20 0.42
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
MAPK1 P28482 1/20 0.41
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7684615 0.81 CRHR1 (0.75) CRHR1
SCHEMBL7687812 0.79 CRHR1 (0.58) CRHR1MAPTHTTLMNA
SCHEMBL7655833 0.75 CA12 (0.50) EGFRPDGFRBPDGFRAKDRSMN1; SMN2
SCHEMBL5014888 0.74 CA12 (0.58) EGFRPDGFRBPDGFRAKDRSMN1; SMN2
SCHEMBL28744369 0.72 MEN1 (0.49) EGFRPDGFRBPDGFRAKDRSMN1; SMN2
SCHEMBL8943694 0.72 CA12 (0.60) SMN1; SMN2KMT2AMAPTCA12CA1
SCHEMBL9290857 0.70 KDM4C (0.48) EGFRPDGFRBPDGFRAKDRSMN1; SMN2
SCHEMBL9290859 0.70 XDH (0.46) EGFRPDGFRBPDGFRAKDRKMT2A
SCHEMBL24315697 0.68 CA12 (0.50) SMN1; SMN2KMT2AMAPTCA12CA1
SCHEMBL24317921 0.68 CA12 (0.50) CRHR1EGFRPDGFRBPDGFRAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP claimed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO claimed
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed